UPDATE 1-Lundbeck raises earnings guidance for the fourth time in 12 months

May 10 (Reuters) - Danish drugmaker Lundbeck raised its financial guidance for the fourth time in 12 months as sales of its anti-epileptic drug Sabril was not dented by copycat competition, as Lundbeck had expected, its chief executive said on Wedneday.

by reutersCOMPANYNEWS via Endless Supplies .Biz - News